Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
Saleh A. Alqahtani, Massimo Colombo
Cells (2021) Vol. 10, Iss. 11, pp. 3091-3091
Open Access | Times Cited: 18

Showing 18 citing articles:

European cancer mortality predictions for the year 2023 with focus on lung cancer
Matteo Malvezzi, Claudia Santucci, Paolo Boffetta, et al.
Annals of Oncology (2023) Vol. 34, Iss. 4, pp. 410-419
Open Access | Times Cited: 92
Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C
Michał Brzdęk, Dorota Zarębska‐Michaluk, Federica Invernizzi, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 6, pp. 949-966
Open Access | Times Cited: 22
Overexpressed or hyperactivated Rac1 as a target to treat hepatocellular carcinoma
Vincent Sauzeau, J. Beignet, Gérard Vergoten, et al.
Pharmacological Research (2022) Vol. 179, pp. 106220-106220
Open Access | Times Cited: 30
Etiologic, epidemic, medical and economic aspects of hepatocellular carcinoma
N. A. Vlasova, В. И. Апанасевич, Е. В. Елисеева, et al.
Сибирский научный медицинский журнал (2025) Vol. 45, Iss. 1, pp. 6-14
Open Access
Based on disulfidptosis, unveiling the prognostic and immunological signatures of Asian hepatocellular carcinoma and identifying the potential therapeutic target ZNF337-AS1
Duo Shen, Ling Sha, Yang Ling, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
Stavros P. Papadakos, Ioanna Ε. Stergiou, Nikolina Gkolemi, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3434-3434
Open Access | Times Cited: 9
Gender disparity and temporal trend of liver cancer in China from 1990 to 2019 and predictions in a 25-year period
Tingting Yue, Ming Xu, Ting Cai, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 13
Prevention of malignant digestive system tumors should focus on the control of chronic inflammation
Yuehua Zhang, Xiaolin Chen, Yiran Wang, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 3, pp. 389-404
Open Access | Times Cited: 5
Hepatocellular organellar abnormalities following elimination of hepatitis C virus
Haruyo Aoyagi, Hiroko Iijima, Eman S. Gaber, et al.
Liver International (2023) Vol. 43, Iss. 8, pp. 1677-1690
Closed Access | Times Cited: 5
Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA
Ji‐Hua Ren, Sheng‐Tao Cheng, Fang Ren, et al.
Genes & Diseases (2024) Vol. 12, Iss. 1, pp. 101215-101215
Open Access | Times Cited: 1
High serum gamma‐glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma
Miyako Murakawa, Mina Nakagawa, Hisaaki Nishimura, et al.
Hepatology Research (2024)
Closed Access | Times Cited: 1
Co-incidence of COVID-19 and hepatocellular carcinoma during pregnancy: Double punches to disease severity and mortality?
Azzaki Abubakar, Fauzi Yusuf, Sarah Firdausa, et al.
Narra J (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 3
Pegylated interferon‐α‐2b combined with tenofovir disoproxil fumarate, granulocyte‐macrophage colony‐stimulating factor, and hepatitis B vaccine treatment for naïve HBeAg‐positive chronic hepatitis B patients: A prospective, multicenter, randomized controlled study
Jiangshan Lian, Wei Kuang, Hongyu Jia, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5475-5483
Closed Access | Times Cited: 5
Well‐controlled viremia reduces the progression of hepatocellular carcinoma in chronic viral hepatitis patients treated with lenvatinib
Ya‐Wen Hsiao, Fai‐Meng Sou, Jing‐Houng Wang, et al.
The Kaohsiung Journal of Medical Sciences (2023) Vol. 39, Iss. 12, pp. 1233-1242
Open Access | Times Cited: 2
We should pay more attention to the complexity of the intrinsic entanglement between GPSM2 and HCC
Sijin Li, Biqiong Ren
Research Square (Research Square) (2024)
Open Access
Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis
Yuanyuan Kong, Yameng Sun, Xiaoning Wu, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1350-1358
Closed Access | Times Cited: 1
Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis
Min Yao, Jianjun Wang, Xiyu Chen, et al.
Hepatobiliary & pancreatic diseases international (2022) Vol. 22, Iss. 3, pp. 263-269
Closed Access | Times Cited: 2
Role of nanocomposites for the prevention and treatment of viral infections in the health care system
Lakshmi Kanth Kotarkonda, Tej Prakash Sinha, Sanjeev Bhoi, et al.
Elsevier eBooks (2023), pp. 219-244
Closed Access
Risk factors of liver malignancies in workers chronically exposed to ionizing radiation
G.V. Zhuntova, М. В. Банникова, Tamara V. Azizova
Ekologiya Cheloveka (Human Ecology) (2022) Vol. 29, Iss. 5, pp. 333-344
Open Access
Page 1

Scroll to top